The AMD Experts
We’re on a mission to eliminate blindness caused by age-related macular degeneration (AMD). Our vision is bold but well within reach.
MacuLogix® is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage AMD patients early, before irreversible vision loss has occurred. We can help you deliver better patient care with the scientifically validated AdaptDx Pro™.
Help us save the eyesight of millions by making early functional testing for AMD a routine part of eye care for your aging patients.
Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.
By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.
Latest News & Upcoming EventsView More
Just by adding dark adaptation testing to your practice, doctors can do more for patients at risk of developing AMD. By Julie Rodman, OD, MSc, FAAO.
New Annual Report Demonstrates How Dark Adaptation Makes AMD Management Easy, Accurate, and Profitable
MacuLogix announces the recent publication of “Practical Opportunities in AMD Management,” the fourth in a series of annual reports aimed at reducing avoidable vision loss.
Theia helps eye care professionals like Mary Miller, CPOT, take care of her patients – which is her favorite part as a technician at Kirman Eye.
Put Our Expertise to Work
Testing with AdaptDx Pro
AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.
Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.